L.L. Miller
Impact in
- Immunology top 10%
- Toxin Mechanisms and Immunotoxins
- Immune Response and Inflammation
- Oncology top 10%
Papers in
-
- Muscle Physiology and Disorders 8
- Cancer therapeutics and mechanisms 4
- Oncology 8
- Cancer Treatment and Pharmacology 3
- Neutropenia and Cancer Infections 3
- HER2/EGFR in Cancer Research 2
- Co-authors
- Gary Elfring (19 shared papers)N A Brophy (1 shared paper)Nancy Wedel (1 shared paper)Archie Khentigan (1 shared paper)R P Mischak (1 shared paper)W. Scott Harkonen (1 shared paper)Maguy Del Rio (1 shared paper)Lynn E. S̄pitler (1 shared paper)
- Journals
- Neuromuscular Disorders (8 papers)Journal of Clinical Oncology (7 papers)Annals of Oncology (4 papers)Journal of Cystic Fibrosis (3 papers)International Journal of Gynecological Cancer (1 paper)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
L.L. Miller
29 papers receiving 893 citations
Peers
Comparison fields: 5 of 83
- Immunology 237
- Oncology 239
- Biotechnology 82
- Pulmonary and Respiratory Medicine 204
- Genetics 139
Countries citing papers authored by L.L. Miller
This map shows the geographic impact of L.L. Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L.L. Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L.L. Miller more than expected).
Fields of papers citing papers by L.L. Miller
This network shows the impact of papers produced by L.L. Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L.L. Miller. The network helps show where L.L. Miller may publish in the future.
Co-authors
The 25 scholars most cited alongside L.L. Miller, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Therapy of patients with malignant melanoma using a monoclonal antimelanoma antibody-ricin A chain immunotoxin. | 1987 | 184 |
| 2 | 2011 | 161 | |
| 3 | 1992 | 145 | |
| 4 | 1999 | 96 | |
| 5 | Phase I dose-finding and pharmacokinetic trial of irinotecan hydrochloride (CPT-11) using a once-every-three-week dosing schedule for patients with advanced solid tumor malignancy. | 2000 | 66 |
| 6 | 2001 | 50 | |
| 7 | 1998 | 48 | |
| 8 | 2001 | 35 | |
| 9 | 1996 | 27 | |
| 10 | 1994 | 24 | |
| 11 | 1992 | 22 | |
| 12 | 2023 | 12 | |
| 13 | 2002 | 12 | |
| 14 | 2010 | 12 | |
| 15 | 2008 | 11 | |
| 16 | 2008 | 8 | |
| 17 | 2007 | 7 | |
| 18 | 1996 | 5 | |
| 19 | 2008 | 5 | |
| 20 | 2009 | 5 |
About L.L. Miller
L.L. Miller is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Neurology and Cell Biology, having authored 30 papers that have together received 955 indexed citations. Recurring topics across this work include Muscle Physiology and Disorders (8 papers), Cancer therapeutics and mechanisms (4 papers), Cancer Treatment and Pharmacology (3 papers), Cystic Fibrosis Research Advances (3 papers), Neutropenia and Cancer Infections (3 papers), Biotin and Related Studies (2 papers), Barrier Structure and Function Studies (2 papers) and HER2/EGFR in Cancer Research (2 papers). The work is most often cited by research in Immunology (237 citations), Oncology (239 citations), Biotechnology (82 citations), Pulmonary and Respiratory Medicine (204 citations) and Genetics (139 citations). L.L. Miller has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Gary Elfring, N A Brophy, Nancy Wedel, Archie Khentigan, R P Mischak, W. Scott Harkonen, Maguy Del Rio, Lynn E. S̄pitler, John W. Smith and William H. Sharfman. Their work appears in journals such as Neuromuscular Disorders, Journal of Clinical Oncology, Annals of Oncology, Journal of Cystic Fibrosis and International Journal of Gynecological Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.